With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using ...

Williams joins a growing list of celebrities who have publicly shared their use of weight loss medications, including Oprah Winfrey, Whoopi Goldberg, singer Meghan Trainor and basketball legend ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.

The 43-year-old tennis legend has opened up on her drastic weight loss journey, revealing that she has shed 31 pounds over the course of the past year. But admitted that she's had a helping hand.

You might just want a couple of bits.” With more than 1.5 million people in the UK now being prescribed GLP-1 drugs like ...

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...

COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that ...

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.